Haber; Edgar

Patent Applications and Registrations

Patent applications and USPTO patent grants for Haber; Edgar.The latest application filed is for "inhibiting formation of atherosclerotic lesions".

Company Profile

0.17.3

Haber; Edgar - Salisbury NH
Haber, Edgar - US
Haber; Edgar - Princeton NJ
Haber; Edgar - Weston MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Inhibiting formation of atherosclerotic lesions App 20090012020 - Lee; Mu-En ; et al.	2009-01-08
Ubiquitination of the transcription factor E2A App 20020128189 - Kho, Choon-Joo ; et al.	2002-09-12
Antibodies that bind to alpha2-antiplasmin crosslinked to fibrin which do not inhibit plasma alpha2-antiplasmin App 20020086025 - Reed, Guy L. ; et al.	2002-07-04
Antibodies that bind to .alpha.2-antiplasmin crosslinked to fibrin which do not inhibit plasma .alpha.2-antiplasmin Grant 5,582,862 - Reed , et al. December 10, 1	1996-12-10
Antioxidant-induced apoptosis in vascular smooth muscle cells Grant 5,571,523 - Lee , et al. November 5, 1	1996-11-05
Heterobifunctional antibodies having dual specificity for fibrin and thrombolylic agents and methods of use Grant 5,453,269 - Haber , et al. September 26, 1	1995-09-26
Fibrin-targeted inhibitors of thrombin Grant 5,443,827 - Haber , et al. August 22, 1	1995-08-22
Method and use for site-specific activation of substances Grant 5,256,413 - Haber , et al. October 26, 1	1993-10-26
Method for early detection of allograft rejection Grant 5,223,241 - Isobe , et al. June 29, 1	1993-06-29
Antibody-thrombolytic agent product and method of use Grant 5,116,613 - Haber , et al. May 26, 1	1992-05-26
Method of producing fibrin-specific monoclonal antibodies lacking fibrinogen-cross-reactivity using fibrin-specific peptides Grant 4,927,916 - Matsueda , et al. May 22, 1	1990-05-22
Fibrin-specific antibodies and method of screening for the antibodies Grant 4,916,070 - Matsueda , et al. April 10, 1	1990-04-10
Monoclonal antidigoxtin antibodies Grant 4,803,167 - Haber , et al. February 7, 1	1989-02-07
Process and apparatus for electrically desorbing components selectively sorbed on an electrolytically conducting barrier Grant 4,661,224 - Goldstein , et al. * April 28, 1	1987-04-28
Process and apparatus for electrically desorbing components selectively sorbed on an electrolytically conducting barrier Grant 4,584,075 - Goldstein , et al. April 22, 1	1986-04-22
Renin inhibitors Grant 4,478,827 - Haber , et al. October 23, 1	1984-10-23
Radiolabeled diagnostic compositions and method for making the same Grant 4,421,735 - Haber , et al. December 20, 1	1983-12-20
Antibody fragment compositions and process Grant 4,355,023 - Ehrlich , et al. October 19, 1	1982-10-19
Process and composition for reducing blood pressure Grant 4,269,827 - Burton , et al. May 26, 1	1981-05-26
Composition and method for determining the size and location of myocardial infarcts Grant 4,036,945 - Haber July 19, 1	1977-07-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.